The report, “US Biotech Market Analysis”, covers the Medical Biotechnology, Agricultural Biotechnology, and Industrial Biotechnology segments of the sector. The research finds out which is the largest segment in the biotechnology sector, and why. It also discusses the wider role of the technology.
According to our report, biotech funding has been a major source of growth in the US biotech industry as venture capital and financing by other sources continue to provide the momentum. The structure of financing has been strengthening over the past few years with IPOs, FPOs, public and private sector, and venture funds contributing significantly to the industry developments. Rising focus of companies towards drug development, increasing coverage of various diseases, and significant market potential are some of the prominent factors propelling investments in the recent years. market research reports
The report also elaborates the important Bio-clusters prevailing in the US and analyses their growth. It observed that California accounted for the highest growth and attracted maximum funds for research activities. How much employment this cluster generated in the biopharmaceutical sector, has also been covered in the study.
Biotechnology is a priority sector for the government, which has been backing significant developments in the industry. The report identifies key trends in the sector. Of these, bio-similars are found to drive the market positively. It also highlights the competitive landscape in the US biotechnology sector, and lists significant developments of the key players in the segment.
The report finds that the future outlook of the US biotech sector is positive with a substantial amount of investment expected in the research and entrepreneurship development in near future.
List of Figures:
Figure 2-1: Global - Biotechnology Market (Billion US$), 2010-2014
Figure 2-2: Biotechnology Market (Billion US$), 2010-2014
Figure 2-3: Share of Public and Private Sector Companies in Biotech Industry (2010)
Figure 2-4: Bio-pharmaceutical Exports (Billion US$), 2005 & 2010
Figure 2-5: Bio-pharmaceutical R&D Expenditure (Billion US$), 2007-2010
Figure 2-6: Farm Scale Revenues from Major Genetically Modified Crops (Billion US$), 2008-2010
Figure 2-7: Ethanol Production (Billion Gallons), 2009-2014
Figure 4-1: Biotech Financing (Billion US$), 2007-2010
Figure 4-2: Biotech Financing by Type (%), 2010
Figure 5-1: Massachusetts - Share in US Biotech Venture Capital Investment (2007-2010)
Figure 5-2: Massachusetts - Number of Drugs under Development Phases
Figure 5-3: New York - Employment in Biotechnology R&D (2007 & 2010)
Figure 6-1: Number of Clinical Trials by Phase (2010)
Figure 6-2: Number of Clinical Trials by Disease Area (2009)
For more information kindly visit :
US Biotech Market Analysis
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter: http://twitter.com/#!/
# # #
Bharat Book Bureau is the leading business information aggregator providing market research reports and online databases. Bharatbook is also into the business of marketing conferences worldwide and undertakes custom research.